OTCMKTS:ABVC American Brivision (Holding) Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding American Brivision (Holding) Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.00 0.00 (0.00 %) (As of 09/30/2020 01:07 PM ET) Add Compare Share Today's Range$3.60Now: $4.00▼$4.0050-Day Range$3.60MA: $3.95▼$4.0552-Week Range$1.05Now: $4.00▼$7.18Volume2,214 shsAverage Volume1,477 shsMarket Capitalization$78.15 millionP/E RatioN/ADividend YieldN/ABeta0.02 ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company's licensed products include ABV-1501, a combination therapy for triple negative breast cancer; ABV-1502, a combination therapy for solid tumors with Anti-PD1; ABV-1503, a combination therapy for chronic lymphocytic leukemia; ABV-1504 for depressive disorders; ABV-1505, a combination therapy for attention deficit hyperactivity disorder; BFC-1401, a vitreous substitute for vitrectomy; and Maitake combination therapy. It has a co-development agreement with Rgene Corporation to develop Maitake combination therapy products, such as ABV-1507 HER2/neu positive breast cancer combination therapy, ABV-1511 pancreatic cancer combination therapy, and ABV-1527 ovary cancer combination therapy; and collaborative agreements with BioLite Inc and BioFirst Corporation. The company was founded in 2015 and is based in Goshen, New York. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for American Brivision (Holding). Previous Next 2.8 Community Rank Outperform VotesAmerican Brivision (Holding) has received 45 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAmerican Brivision (Holding) has received 36 “underperform” votes. (Add your “underperform” vote.)Community SentimentAmerican Brivision (Holding) has received 55.56% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about American Brivision (Holding) and other stocks. Vote “Outperform” if you believe ABVC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABVC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAmerican Brivision (Holding) does not currently pay a dividend.Dividend GrowthAmerican Brivision (Holding) does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, American Brivision (Holding) insiders have not sold or bought any company stock.Percentage Held by Insiders49.60% of the stock of American Brivision (Holding) is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.76 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ABVC Previous Symbol CUSIPN/A CIK1173313 Webwww.ambrivis.com Phone845-291-1291Debt Debt-to-Equity RatioN/A Current Ratio0.21 Quick Ratio0.21Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$10,000.00 Price / Sales7,815.20 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on Assets-72.25%Miscellaneous Employees9 Outstanding Shares19,538,000Market Cap$78.15 million Next Earnings Date10/2/2020 (Estimated) OptionableNot Optionable $4.00 0.00 (0.00 %) (As of 09/30/2020 01:07 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ABVC News and Ratings via Email Sign-up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter. American Brivision (Holding) (OTCMKTS:ABVC) Frequently Asked Questions How has American Brivision (Holding)'s stock price been impacted by Coronavirus (COVID-19)? American Brivision (Holding)'s stock was trading at $2.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ABVC shares have increased by 37.9% and is now trading at $4.00. View which stocks have been most impacted by COVID-19. When is American Brivision (Holding)'s next earnings date? American Brivision (Holding) is scheduled to release its next quarterly earnings announcement on Friday, October 2nd 2020. View our earnings forecast for American Brivision (Holding). Who are some of American Brivision (Holding)'s key competitors? Some companies that are related to American Brivision (Holding) include Wave Life Sciences (WVE), Catalyst Pharmaceuticals (CPRX), CytomX Therapeutics (CTMX), IMV (IMV), Concert Pharmaceuticals (CNCE), Urovant Sciences (UROV), Cassava Sciences (SAVA), Aldeyra Therapeutics (ALDX), Osmotica Pharmaceuticals (OSMT), VYNE Therapeutics (VYNE), Immunic (IMUX), Xeris Pharmaceuticals (XERS), Selecta Biosciences (SELB), Agile Therapeutics (AGRX) and Liminal BioSciences (LMNL). View all competitors. Who are American Brivision (Holding)'s key executives? American Brivision (Holding)'s management team includes the following people: Mr. Eugene Jiang, Chairman & Interim CFO (Age 33)Dr. Howard Doong, CEO & Pres (Age 62)Dr. Chi-Hsin King, Chief Scientific Officer (Age 71)Ms. Kira Huang, Consultant (Age 49)Dr. Tsung-Shann Jiang, Chief Strategy Officer & Director (Age 64) What is American Brivision (Holding)'s stock symbol? American Brivision (Holding) trades on the OTCMKTS under the ticker symbol "ABVC." How do I buy shares of American Brivision (Holding)? Shares of ABVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is American Brivision (Holding)'s stock price today? One share of ABVC stock can currently be purchased for approximately $4.00. How big of a company is American Brivision (Holding)? American Brivision (Holding) has a market capitalization of $78.15 million and generates $10,000.00 in revenue each year. American Brivision (Holding) employs 9 workers across the globe. What is American Brivision (Holding)'s official website? The official website for American Brivision (Holding) is www.ambrivis.com. How can I contact American Brivision (Holding)? American Brivision (Holding)'s mailing address is 44370 Old Warm Springs Blvd, Fremont CA, 94538. The company can be reached via phone at 845-291-1291. This page was last updated on 10/1/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
